Sep 2026· Current Issues in Molecular Biology· Vol 48· 0 citations· 152 references
Medicine
TL;DR
This review systematically summarizes the molecular mechanisms and enzymatic basis of lactylation, as well as its regulatory functions in core cancer hallmarks and the immune microenvironment, evaluates the translational prospects of targeting the lactate–lactylation axis, and discusses the key scientific questions and future research directions currently facing the field.
Abstract
Lysine lactylation (Kla) is a lactate-driven post-translational modification that covalently links lactyl groups to lysine residues, directly coupling cellular metabolic states to gene expression regulation and protein functional remodeling. Since its first report in 2019, extensive studies have confirmed that lactylation is broadly present on histones and thousands of non-histone substrates. In the context of tumor biology, lactylation reinforces glycolysis through positive feedback loops, suppresses oxidative phosphorylation, remodels lipid and glutamine metabolism, and exerts regulatory functions in autophagy, pyroptosis, ferroptosis, and apoptosis, thereby comprehensively participating in tumor cell proliferation, metabolic adaptation, cell death resistance, and invasion and metastasis. Within the tumor microenvironment, lactylation constructs an immune evasion barrier by upregulating immune checkpoints, including programmed death-ligand 1 (PD-L1), driving tumor-associated macrophage polarization toward the M2 phenotype, inducing CD8+ T cell exhaustion, and enhancing regulatory T cell suppressive function. Strategies targeting lactate production (lactate dehydrogenase A (LDHA) inhibitors), lactate transport (monocarboxylate transporter (MCT) inhibitors), and the lactylation enzymatic machinery (p300/CBP inhibitors, histone deacetylase (HDAC) inhibitors) have shown promising results in preclinical models, and a limited number of agents, including the MCT1 inhibitor AZD3965 and the p300/CBP inhibitor CCS1477, have entered early-phase clinical trials primarily for safety and tolerability assessment. This review systematically summarizes the molecular mechanisms and enzymatic basis of lactylation, as well as its regulatory functions in core cancer hallmarks and the immune microenvironment, evaluates the translational prospects of targeting the lactate–lactylation axis, and discusses the key scientific questions and future research directions currently facing the field.
A deeper understanding of lactate flux and lactylation-dependent vulnerabilities may enable biomarker-guided combinations that integrate metabolic intervention, epigenetic modulation, and immuno-oncology for precision cancer therapy.
Jia-Yi Chen, An-Qi He, Si-Yi Zhu et al.· Journal of Pathology· 0 citations
This review systematically summarizes current progress on the lactate-Kla axis in glioma, encompassing the basis of lactate metabolism, the molecular regulatory network of Kla, and the distinct yet coordinated functions of histone and non-histone lactylation.
Xiao-Song Hu, Li Yang, Yang-Hao Hu et al.· Frontiers in Cell and Develo...· 0 citations
Lactate and lactate-mediated protein lactylation are no longer viewed merely as accompanying phenomena of enhanced glycolysis, hypoxic responses, or tissue acidification. They are now recognized as an important regulatory axis that links local metabolic stress to chromatin regulation and altered protein function. With...
Glioblastoma (GBM) is one of the most aggressive primary malignant tumors in the central nervous system. It is characterized by significant metabolic reprogramming, obvious glycolysis dependence, and excessive lactate accumulation. Rather than being merely a metabolic by-product, lactate is increasingly recognized as a...
Long Huang, Bo-Yu Huang, Shi-Zhen Kuang et al.· Frontiers in Cell and Develo...· 0 citations
How non-histone lactylation regulates the metastatic cascade is synthesized using a three-tier confidence framework distinguishing fully characterized circuits from proteomic screening hits, and therapeutic strategies ranging direct lactylation machinery inhibitors from indirect lactate-axis modulators are discussed.
Mithu Howlader, A. Akinyemi, Md Rakibul Alam et al.· Biochemical Pharmacology· 0 citations
Metabolic reprogramming and immune evasion are hallmarks of cancer. Although leucine is well known for regulating protein synthesis, its role in immunometabolic interactions within the tumor microenvironment (TME) remains unclear. In this study, we found that leucine supplementation significantly inhibited tumor growth...